Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploring Immune Development in Infants With Moderate to Severe Atopic Dermatitis.
Hulshof L, Overbeek SA, Wyllie AL, Chu MLJN, Bogaert D, de Jager W, Knippels LMJ, Sanders EAM, van Aalderen WMC, Garssen J, Van't Land B, Sprikkelman AB; Clinical Study Group. Hulshof L, et al. Among authors: de jager w. Front Immunol. 2018 Mar 29;9:630. doi: 10.3389/fimmu.2018.00630. eCollection 2018. Front Immunol. 2018. PMID: 29966024 Free PMC article. Clinical Trial.
Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndrome.
van den Hoogen LL, van Roon JAG, Mertens JS, Wienke J, Lopes AP, de Jager W, Rossato M, Pandit A, Wichers CGK, van Wijk F, Fritsch-Stork RDE, Radstake TRDJ. van den Hoogen LL, et al. Among authors: de jager w. Ann Rheum Dis. 2018 Dec;77(12):1810-1814. doi: 10.1136/annrheumdis-2018-213497. Epub 2018 Sep 5. Ann Rheum Dis. 2018. PMID: 30185417
Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular risk.
Wienke J, Mertens JS, Garcia S, Lim J, Wijngaarde CA, Yeo JG, Meyer A, van den Hoogen LL, Tekstra J, Hoogendijk JE, Otten HG, Fritsch-Stork RDE, de Jager W, Seyger MMB, Thurlings RM, de Jong EMGJ, van der Kooi AJ, van der Pol WL; Dutch Juvenile Myositis Consortium; Arkachaisri T, Radstake TRDJ, van Royen-Kerkhof A, van Wijk F. Wienke J, et al. Among authors: de jong emgj, de jager w. Rheumatology (Oxford). 2021 Feb 1;60(2):785-801. doi: 10.1093/rheumatology/keaa270. Rheumatology (Oxford). 2021. PMID: 32810267
The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10.
de Kleer IM, Kamphuis SM, Rijkers GT, Scholtens L, Gordon G, De Jager W, Häfner R, van de Zee R, van Eden W, Kuis W, Prakken BJ. de Kleer IM, et al. Among authors: de jager w. Arthritis Rheum. 2003 Jul;48(7):2001-10. doi: 10.1002/art.11174. Arthritis Rheum. 2003. PMID: 12847694 Free article.
Novel self-epitopes derived from aggrecan, fibrillin, and matrix metalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health.
Kamphuis S, Hrafnkelsdóttir K, Klein MR, de Jager W, Haverkamp MH, van Bilsen JH, Albani S, Kuis W, Wauben MH, Prakken BJ. Kamphuis S, et al. Among authors: de jager w. Arthritis Res Ther. 2006;8(6):R178. doi: 10.1186/ar2088. Arthritis Res Ther. 2006. PMID: 17129378 Free PMC article.
127 results